James Hays, MD
Cardiovascular Disease · Jackson, MSNPI 1912943945
Payments from drug & device makers
Across 383 payments — averaging $169.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$19K
- Boehringer Ingelheim International GmbH$18K
- Amgen$11K
- Edwards Lifesciences$7K
- Boehringer Ingelheim Pharma GmbH & Co.kg$4K
- Medtronic$1K
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 98 | $19,153 |
| Boehringer Ingelheim International GmbH | 67 | $18,177 |
| Amgen | 25 | $10,630 |
| Edwards Lifesciences | 7 | $7,193 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $4,066 |
| Medtronic | 59 | $1,392 |
| Abiomed | 22 | $983 |
| Boston Scientific | 9 | $741 |
| Merck | 18 | $415 |
| AstraZeneca | 8 | $255 |
| Glaukos Corporation | 1 | $187 |
| Novo Nordisk | 4 | $186 |
| Pfizer | 11 | $180 |
| Johnson & Johnson | 12 | $164 |
| Abbott | 7 | $154 |
| Inspire Medical Systems, Inc. | 1 | $132 |
| Shockwave Medical, Inc | 1 | $132 |
| Boehringer Ingelheim | 2 | $113 |
| Atricure, Inc. | 1 | $111 |
| Bayer | 2 | $110 |
| Philips North America LLC | 6 | $99 |
| Irhythm Technologies, Inc. | 1 | $86 |
| Akcea Therapeutics, Inc. | 1 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $62 |
| Heartflow, Inc. | 1 | $52 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $26 |
| Cvrx, Inc. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Impulse Dynamics (USA) Inc. | 1 | $18 |
| GSK | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $11 |
How this compares
$65,061 in reported general payments places this provider in the 95th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Jackson
- James HaysJackson$782K
- Donny StokesJackson$277K
- James BenslerJackson$64K
- Michael HallJackson$54K
- James WarnockJackson$48K
- Tahsin QarqishJackson$39K
- Christopher LatourJackson$33K
- Kenneth MonahanJackson$31K
- Varun SardarJackson$31K
- Berthrone Mock-MuhammadJackson$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.